Radioactivity can save lives. When neither chemotherapy or surgery nor radiation from the outside help against a tumor, modern medicine uses so-called radiopharmaceuticals. These radioactive drugs not only detect cancer cells, they also enable targeted radiation from the inside to destroy the tumor. However, before such substances become available for use in humans, extensive animal testing is currently required during their development. A joint project of the Fraunhofer Institute for Material and Beam Technology IWS in Dresden and the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) is currently researching an alternative method to this. Artificial organ structures and tumors in chip format form the basis for this.
In November, we visited the international trade fair for innovative industrial solutions "Warsaw Industry Week" together with our Polish cooperation partners. At the fair mainly Polish players of the machine and tool building industry as well as the processing of metal, wood and plastics present themselves.
Sustainable cross-border cooperation between research institutes and SMEs in Poland and Germany in the field of medical technology is one of the central concerns of the ATeM high-performance center. The fourth Saxon-Polish Innovation Day on September 15 and 16 was the perfect opportunity to exchange ideas with stakeholders from science and industry from Saxony and the Republic of Poland.